Bloomage Net Income From Continuing Ops from 2010 to 2024
| 688363 Stock | 60.32 1.16 1.96% |
Net Income From Continuing Ops | First Reported 2019-03-31 | Previous Quarter 243.4 M | Current Value 97.1 M | Quarterly Volatility 58.2 M |
Check Bloomage Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bloomage Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 11.3 M, Other Operating Expenses of 6.3 B or Net Income Applicable To Common Shares of 562.4 M, as well as many indicators such as . Bloomage financial statements analysis is a perfect complement when working with Bloomage Biotechnology Valuation or Volatility modules.
Bloomage | Net Income From Continuing Ops |
Currently Active Assets on Macroaxis
Other Information on Investing in Bloomage Stock
Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.